In addition, SLE-PBMCs (p < 0.0001) and UCB-Treg: SLE-PBMC coculture (p < 0.01) showed a significant reduction of p-STAT5+CD8+ T cells after treatment with 100 nM ruxolitinib. The gene discussed is CD8A; the disease is systemic lupus erythematosus.